News Conference News ESC 2018 My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More Shelley Wood September 14, 2018
News Conference News ESC 2018 FFRCT Shifts Patient Management, Linked to Better 90-Day Outcomes: ADVANCE Registry Caitlin E. Cox September 07, 2018
News Conference News ESC 2018 Myocardial Injury or MI? New Universal Definition Aims for Clarity Todd Neale September 05, 2018
News Conference News ESC 2018 Updated ESC Guidelines Introduce Concept of a Pregnancy Heart Team for Women With CVD Todd Neale August 31, 2018
News Conference News ESC 2018 ASCOT Legacy: Calcium Channel Blockers, Statins Confer Long-term Survival Benefits in Hypertensive Patients L.A. McKeown August 31, 2018
News Conference News ESC 2018 SCOT-HEART: A Win for CT Angiography in Chest Pain Workup Prompts Cacophony of Reactions Shelley Wood August 31, 2018
News Conference News ESC 2018 High-STEACS: Sensitive Troponin Tests Rule Out MI, but Have No Impact on Hard Events Shelley Wood August 29, 2018
News Conference News ESC 2018 New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All Michael O'Riordan August 29, 2018
News Conference News ESC 2018 Pretreatment With P2Y12 Inhibitors Questioned Anew in SCAAR Shelley Wood August 28, 2018
News Conference News ESC 2018 Redefined ‘High-Quality’ Diet Lowers Risk of All-Cause Mortality: PURE Michael O'Riordan August 28, 2018
News Conference News ESC 2018 Tafamidis, a Transthyretin Stabilizer, Offers Hope for Rare Cardiomyopathy Michael O'Riordan August 27, 2018
News Conference News ESC 2018 Sobering News From Europe: CVD Risk Factors Are on the Rise or Holding Firm Todd Neale August 27, 2018
News Conference News ESC 2018 COMMANDER HF: Low-Dose Rivaroxaban Flops in Heart Failure Todd Neale August 27, 2018
News Conference News ESC 2018 MITRA-FR: No Benefit of MitraClip in Functional MR Shelley Wood August 27, 2018
News Conference News ESC 2018 Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND Michael O'Riordan August 26, 2018
News Conference News ESC 2018 MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis Todd Neale August 26, 2018
News Conference News ESC 2018 Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE Shelley Wood August 26, 2018
News Conference News ESC 2018 Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61 Michael O'Riordan August 26, 2018
News Conference News ESC 2018 CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD Shelley Wood August 25, 2018
News Conference News ESC 2018 CULPRIT-SHOCK: 1-Year Results Continue to Support Culprit-Only PCI for Shock Patients Todd Neale August 25, 2018